The Insight Study

A phase 3 study of ripretinib versus sunitinib in patients with advanced gastrointestinal stromal tumor (GIST) with specific KIT mutations who were previously treated with imatinib.

Find a study location near you

Take the next step

Contact your doctor to discuss the INSIGHT Study. To help start the conversation, take a look at our discussion guide containing questions to ask your doctor.

Questions to discuss with your doctor

Download the Discussion Guide